- ISO 17025 lab-tested
- 99%+ purity
- Research use only
Tirzepatide
-
Processed as soon as payment clears
Packed and dispatched without delay.
-
Free shipping over €99.00 to most EU countries
-
Shipment protection included
Lost or damaged in transit? We send a replacement.
-
Discreet packaging
Plain parcel, no product names on the outside.
-
We accept
Secure checkout
- SEPA bank transfer
Independent lab results
Tested before it reaches your bench
Every batch is analysed by an independent, ISO 17025-accredited laboratory before release. The report shown here belongs to the batch now shipping, so what you read is what you receive.
Analiza Białek sp. z o.o.
ISO/IEC 17025 accredited
HPLC purity
99%
Release minimum: 99%
- Lot
- TR10/012026
- Tested
- July 2, 2026
- Measured
- 10.00 mg
- Report no.
- T6J8M1S2
- Size tested
- 10mg
- Batch-specific
- Independent lab
Quality control results
1 passed · 1 reported-
Purity
Reversed-phase HPLC
99% Pass -
Net peptide content
HPLC quantitation
10.00 mg Reported
Tests in our panel
- Visual inspection · Colour, form and integrity of the lyophilised powder and the vial seal, checked against the specification.
- LC-MS · Confirms the molecular mass matches the expected structure of the compound.
- Impurity profile · Checks for residues from synthesis and handling that should not be present.
- Elemental analysis · Screens for toxic metals that can enter through raw materials or equipment.
- Microbial culture · Checks a sample for bacterial and fungal growth.
- Endotoxin assay · Measures bacterial endotoxins, reported in endotoxin units (EU) per vial.
All published batches
Every lot of this product we have released, each with its own certificate. Newest first.
Tirzepatide
LatestLOT TR10/012026
99%
HPLC purity
- Measured content
- 10.00 mg
- Tested on
- July 2, 2026
2 assays by Analiza Białek sp. z o.o.
Open certificateTechnical specifications
Compound at a glance
Molecular profile
Tirzepatide
- Compound class
- GIP / GLP-1 dual receptor agonist
- CAS number
- 2023788-19-2
- Molecular weight
- 4,813 Da
- Molecular formula
- C225H348N48O68
- Amino acids
- 39 amino acids
- Reported half-life
- ~5 days
- Research area
- Incretin & glucose-metabolism research
Handling
Storage and stability
- −20 °C as powder
- 2–8 °C in solution
- Protect from light
- Keep dry
Lyophilised powder
−20 °C, protected from light and moisture
In solution
2 to 8 °C
General guidance for laboratory storage. Follow your institution’s handling procedures.
About this compound
Tirzepatide – Dual-Agonist Peptide for Metabolic & Weight Management
- Composition: Tirzepatide (lyophilized peptide powder)
- Category: Peptide
- Form: Vial with freeze-dried powder
What is Tirzepatide?
Tirzepatide is a dual incretin receptor agonist that simultaneously activates the GLP-1 (Glucagon-Like Peptide-1)and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors.
This dual mechanism makes it a next-generation peptide in metabolic and weight regulation research, combining the glucose-lowering effects of GLP-1 agonists with the metabolic advantages of GIP stimulation.
By activating both signaling pathways, Tirzepatide has shown strong potential in preclinical and clinical studies for improving insulin sensitivity, reducing body fat, and optimizing energy metabolism.
Ideal for metabolic health, insulin regulation, and obesity mechanism research.
Key Research Findings
Dual Receptor Activation: Stimulates both GLP-1 and GIP receptors for synergistic metabolic enhancement.
Glucose Regulation: Promotes insulin secretion and improves glucose homeostasis.
Appetite Control: Regulates central mechanisms controlling hunger and satiety.
Energy Metabolism: Enhances mitochondrial efficiency and fat oxidation.
Storage Instructions
- Store at 2–8 °C (36–46 °F)
- Protect from light and moisture
- Do not freeze
- Avoid temperature fluctuations
Why Choose Tirzepatide?
Tirzepatide is one of the most advanced incretin-based peptides currently under research.
Through its dual receptor activation, it offers a unique profile for optimized metabolic control and weight management.
Its effects on glucose metabolism, fat oxidation, and energy balance make it a valuable tool in endocrine and metabolic research.
Order Tirzepatide and explore its potential in advanced metabolic and obesity research.
Research notice
For laboratory research use only. This product is not a medicinal product or a food. It is not intended for human or veterinary use, or for any diagnostic or therapeutic purpose.
The buyer is responsible for receiving, storing, handling and disposing of this material safely and lawfully, in line with the rules of their country and institution. We sell only to adults aged 18 or over who are qualified to work with research materials.
Descriptions on this page summarise published research for educational purposes. They are not medical advice and make no claim about safety or effects in humans.
